Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Superior Prima Sukses Tbk. (BLES) vs Brigit Biofarmaka Teknologi Tbk. (OBAT) Price & Performance

Superior Prima Sukses Tbk.Trade
Brigit Biofarmaka Teknologi Tbk.Trade

Price performance (Past 24H)

Key statistics

Superior Prima Sukses Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Superior Prima Sukses Tbk. trades at Rp204 (market cap 1.85T, 10.06M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 164.65B, 187.4K 24h volume). The key difference: Superior Prima Sukses Tbk. is far larger — about 11.2× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Superior Prima Sukses Tbk. is more actively traded (10.06M versus 187.4K). Which is the better fit depends on your goals.

BLESOBAT
Market Cap
1.85T164.65B
Volume
10.06M187.4K
Lot
100.63K1.87K
Turnover
2.05B44.35M
Average Price
204.06236.67
Value
2.05B44.35M
Indicative Equilibrium Price
204242
Indicative Equilibrium Volume
395500

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

BLES
View details
OBAT
View details

About Superior Prima Sukses Tbk.

PT Superior Prima Sukses Tbk (the Company) was established based on Notarial Deed of Sriwati, S.H., M.Hum., No. 8 dated November 3, 2011. The Company started its operations in April 2013. PT Global Base Universal is the ultimate parent entity of the Company.

Read more on BLES

About Brigit Biofarmaka Teknologi Tbk.

PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.

Read more on OBAT